Gelteq Announces Largest U.S. Customer Increases Initial Order by 50% to Meet Growing Market Demand
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Dec 02 2024
0mins
Source: Newsfilter
Gelteq's Partnership Expansion: Gelteq Limited has announced a 50% increase in the purchase order from its largest U.S. customer, Healthy Extracts, for collagen and sugar blocker gels due to high demand, supporting Gelteq's strategic growth in the U.S. market.
Innovative Delivery Solutions: Gelteq focuses on developing gel-based delivery solutions that improve ingestion and absorption of nutraceuticals, with plans to introduce new products in early 2025 as part of their collaboration with Healthy Extracts.
Analyst Views on GELS
About GELS
Gelteq Limited is an Australia-based clinical and science-based company. The Company is focused on developing and commercializing white-label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products. The Company offers a complete end-to-end service for the development of new products and the conversion of existing products and formulations into gels. Its product suite consists of multiple products that sit within five core verticals - for pets, sports, pharmaceuticals (pharma), over-the-counter (OTC) and nutraceuticals. The Company’s delivery system provides pharma and nutraceutical enhancements throughout every stage of ingestion in both animals and humans, addressing the complete experience from the point of ingestion to final absorption. The Company also offers a versatile portfolio of pre-tested and market-ready proprietary formulations that can be white-labelled.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
